Medicare reviews anemia drug use; Cleveland Clinic focuses on telemedicine;

> Medicare is pulling together a panel to discuss the best uses for anemia drugs Procrit, Aranesp and Epogen in chronic kidney disease. This isn't a big thrill for drugmakers Amgen and Johnson & Johnson, of course, who fear more restrictions. FiercePharma

> The Cleveland Clinic is planning a new focus on telemedicine initiatives, including eICUs and home healthcare support. FierceHealthIT

> A Boston hospital expects to save $7 million per year with an automated referral system. FierceHealthFinance

> Researchers have found a link between blood pressure and multiple sclerosis that could open an avenue to an inexpensive approach for treating the disabling condition. FierceBiotechResearch

And Finally... I bet this is the most interesting thing, by a huge margin, that he's ever found in the rough. Article